Metaphore Biotechnologies is a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. Their MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.

Metaphore Biotechnologies

Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.  

Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.

Flagship Pioneering

Congratulations to our Co-Founder and CEO Lovisa Afzelius for being recognized by PharmaVoice as a top 100 leader in the life science industry! Lovisa’s passion to drive the industry forward is apparent and we are proud to have her leading our team.

Read more about what keeps Lovisa inspired, what she sees as the future of AI, and more as she and her peers chart new paths: https://lnkd.in/evrPFA_x

We are proud to be one of four innovative bioplatform companies Flagship Pioneering has launched in the last year that are working to improve human health.  
 
At Metaphore, our mission is to harness the power of biomimicry to develop therapeutics that outperform today’s drugs and make previously intractable targets accessible. Read more: https://lnkd.in/eibnG2aM

We started with a question: “What if we could engineer therapeutics to trigger the desired biological response in a programmable way?”  
 
In nature, creatures have evolved to mimic each other for adaptive advantage. Take the owl butterfly, a physically vulnerable creature whose wings harness the power of an owl just by mimicking the image of the predator’s eye. We challenged ourselves to see how biomimicry could be applied to therapeutics, at a molecular level.  
 
Today, we introduce Metaphore Biotechnologies, founded by Flagship Pioneering as the answer to that challenge. We built Metaphore around the MIMiC™ platform, a premier computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized.  
 
We aspire to make therapeutics that outperform today’s drugs and reach patients with few or no therapeutic options. And we invite you to follow us as we go on that journey.  
 
Learn more: https://lnkd.in/eUYBxpzF
 
#FlagshipFounded #machinelearning

COM:METAPHOREBIO

Metaphore Biotechnologies

Financials Not Available